
Opinion|Videos|October 24, 2024
Effective Balance of Approved Therapies and Patient Preferences
Author(s)Stuart H. Isaacson, MD, FAAN
Key Takeaways
- Patient-centered care involves understanding patient values and preferences alongside clinical efficacy and safety of therapies.
- Open communication and shared decision-making empower patients to actively participate in their treatment plans.
Dr. Isaacson discusses how health care providers can effectively balance the pharmacological properties of approved therapies for Parkinson's disease with patient preferences and comfort levels by fostering open communication and individualized care approaches.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How can healthcare providers effectively balance pharmacological properties of approved therapies with patient preferences and comfort levels?
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Remyelinating Agent PIPE-307 Falls Short in Phase 2 Trial of Relapsing Multiple Sclerosis
2
Brain-Penetrant Molecule GT-02287 Demonstrates Reversal of Glucosylsphinogosine in Parkinson Disease
3
NeuroVoices: Joseph Sullivan, MD, on ETX101 Gene Regulation Therapy and Early POLARIS Findings in Dravet Syndrome
4
Vamorolone’s Cardiac Rationale in Duchenne Muscular Dystrophy
5























